Table 1.
Baseline characteristics of the sample stratified by diagnostic group (n░=░4989)a.
| Characteristic | Category | Total n (%) (n░=░4989) |
SMI n (%) (n░=░450) |
DD n (%) (n░=░1235) |
None n (%) (n░=░3304) |
Chi-square test |
DF |
|---|---|---|---|---|---|---|---|
| Age (years) | 21.34 | 4 | |||||
| ≤39 | 2214 (44.4) | 181 (40.2) | 535 (43.3) | 1498 (45.4) | |||
| 40–49 | 1961 (39.3) | 207 (46.0) | 523 (42.3) | 1231 (37.3) | |||
| ≥50 | 813 (16.3) | 62 (13.8) | 177 (14.3) | 574 (17.4) | |||
| Sex | 57.18 | 2 | |||||
| Male | 3538 (71.3) | 277 (62.1) | 804 (65.6) | 2457 (74.7) | |||
| Female | 1421 (28.7) | 169 (37.9) | 422 (34.4) | 830 (25.3) | |||
| Race | 26.50 | 4 | |||||
| Black | 2100 (42.1) | 160 (35.6) | 503 (40.7) | 1437 (43.5) | |||
| Hispanic/other | 1593 (31.9) | 180 (40.0) | 366 (29.6) | 1047 (31.7) | |||
| White | 1295 (26.0) | 110 (24.4) | 366 (29.6) | 819 (24.8) | |||
| Nadir CD4 cell count (cells/μl) |
12.32 | 6 | |||||
| <50 | 1168 (23.4) | 104 (23.1) | 253 (20.5) | 811 (24.5) | |||
| 50–200 | 1562 (31.3) | 135 (30.0) | 407 (33.0) | 1020 (30.9) | |||
| 201–500 | 1718 (34.4) | 161 (35.8) | 453 (36.7) | 1104 (33.4) | |||
| >500 | 541 (10.8) | 50 (11.1) | 122 (9.9) | 369 (11.2) | |||
| Prior history of IDU |
42.08 | 2 | |||||
| No | 3570 (72.2) | 288 (64.3) | 824 (67.3) | 2458 (75.1) | |||
| Yes | 1378 (27.8) | 160 (35.7) | 401 (32.7) | 817 (24.9) | |||
| No. of MH visits |
1424.13 | 8 | |||||
| 0 | 3629 (72.7) | 123 (27.3) | 577 (46.7) | 2929 (88.7) | |||
| 1 | 444 (8.9) | 63 (14.0) | 200 (16.2) | 181 (5.5) | |||
| 2–5 | 587 (11.8) | 159 (35.3) | 275 (22.3) | 153 (4.6) | |||
| 6–11 | 191 (3.8) | 61 (13.6) | 99 (8.0) | 31 (0.9) | |||
| ≥12 | 138 (2.8) | 44 (9.8) | 84 (6.8) | 10 (0.3) |
DD, depressive disorder; DF, degree of freedom; IDU, injection drug use; MH, mental health; SMI, serious mental illness.
Sample includes five sites. Patients were observed to go on HAART sometime during the years 2001–2005.
Baseline is the year patient started HAART.
Reported P values are from chi-square tests of equal categorical distributions across the three diagnostic groups.